Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)
Followed By 179
Posts 9336
Boards Moderated 0
Alias Born 08/14/2003

Thursday, June 16, 2022 2:51:25 PM

Re: IkeEsq post# 487317

Post# of 506050

I can certainly agree the company has no control of the Journal, but I do believe that they should know its current status and any issues that remain to be resolved. They should have some idea of how long it will take.

As for the Annual Meeting having little or no import, I believe it all depends on how much information they release before the meeting. If we get the Journal, the TLD statement, and the company breaks the quiet period prior to the meeting and gives us the status of their approaching the regulators, the FlaskWorks unit certification, etc. then there may be little meaningful discussion at the meeting because they acted before the meeting. On the other hand they could wait for the Annual Meeting to break the quiet period, then it could be meaningful.

If we don't have the Journal by early July you may be correct that the meeting may not occur in July at all, or later in July if the Journal comes by mid month. I do not believe the company will ask investors to vote to authorize additional shares prior to the Journal being available.

If the Journal is not held up by anything due from Dr. Liau or the company, but rather were awaiting the official guidance change by the FDA, then no telling how long the Journal will be on hold. The Annuls of Oncology article by the FDA staff clearly specifies their intent to make the change, but if the Journal were insisting on the formal change being issued, no telling how long we may have to wait.

Recent NWBO News

PSYC Appoints COO for Wholly Owned Subsidiary, Spotlight Media Corp. PSYC Aug 17, 2022 8:30 AM

ResGreen Group Adds Wireless Stacklights to its Line-Up of Industrial Automation Devices RGGI Aug 17, 2022 7:41 AM

GBT Filed a Non-Provisional Patent Application Seeking to Protect the Automatic Correction of Integrated Circuits Connectivity Mismatches GTCH Aug 16, 2022 4:56 PM

InnerScope Hearing Technologies (OTC: INND) Announces FDA Has Released The Final Rule For OTC Hearing Aids INND Aug 16, 2022 11:29 AM

FDCTech's Quarterly Release for the Second Quarter (FY22 Q2) Results FDCT Aug 16, 2022 9:42 AM

Fastbase (OTC:FBSE) Explodes Data Research Space FBSE Aug 16, 2022 9:15 AM

WaterPure International Inc (OTCMKTS: WPUR) Heating Up after Co Announces it is Exploring Multiple Merger & Acquisition Opportunities INTK Aug 16, 2022 9:00 AM

PSYC Enters MOU to Acquire Technical420, LLC for $2.25M in Accretive Transaction PSYC Aug 16, 2022 8:30 AM

Branded Legacy, Inc. Announces Removal of "Yield" Sign on OTC Markets Stock Quotes BLEG Aug 16, 2022 8:30 AM

HealthLynked Reports Second Quarter 2022 Results HLYK Aug 16, 2022 8:00 AM

XCPCNL Business Services Announces Signing of Reverse Merger Acquisition Agreements with Centiment Capital Holdings XCPL Aug 16, 2022 7:15 AM

ILUS Confirms Its Second Quarter of 2022 Results, Including a 553% Revenue Increase Over Its Previous Quarter, to $19,677,222 ILUS Aug 15, 2022 2:52 PM

S.E.C.-registered HYUNDAI brand consumer technologies enters the U.S. market with a $100 million stocks and bond offering Aug 15, 2022 12:04 PM

Branded Legacy, Inc. Reduces Issued and Outstanding Shares By 46% BLEG Aug 15, 2022 8:30 AM

Green Battery Minerals Receives Assays from Drilling into Graphite Outcrops on Zone 1. Intersecting 19.5 metres of 35.52% Grade Graphite and 51.20 meters of 22.61% Grade Graphite. GEM Aug 12, 2022 6:07 PM

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y